DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Palifosfamide is an investigational drug.
There have been 8 clinical trials for Palifosfamide. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2010.
The most common disease conditions in clinical trials are Testicular Neoplasms, Sarcoma, and Small Cell Lung Carcinoma. The leading clinical trial sponsors are Ziopharm, Indiana University School of Medicine, and [disabled in preview].
Recent Clinical Trials for Palifosfamide
|Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.||Ziopharm||Phase 2|
|Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors||Ziopharm||Phase 2|
|Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors||Indiana University School of Medicine||Phase 2|